Benzonatate 62135-0441
Product NDC
62135-0441- Manufacturer
- Chartwell Rx, Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2018
- Listing Expires
- December 31, 2026
- Application
- ANDA040682
Need to source Benzonatate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Benzonatate | 200 mg/1 |
Drug Class
Non-narcotic Antitussive [EPC]Decreased Tracheobronchial Stretch Receptor Activity [PE]Non-narcotic Antitussive [EPC]
Packaging Options(2)
300 CAPSULE in 1 BOTTLE (62135-441-31)
60 CAPSULE in 1 BOTTLE (62135-441-60)